AM-2201
3 ★
3 ★
18 Ratings
5 ★
0
4 ★
1
3 ★
0
2 ★
1
1 ★
0
(18)
Highlights:
AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor.[1] It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.
$265.00 – $3,200.00